Syncona Limited

Corporate Details

ISIN(s):

GG00B8P59C08

LEI:

213800X8MBI5VQITLW60

Country:

Guernsey

Address:

FRANCES HOUSE, P O BOX 273, GY1 3RD ST PETER PORT

Website:

https://www.synconaltd.com/

Sector:

Financials

Industry:

Capital Markets

Description

Syncona Limited is an investment company with a focus on healthcare. Based in London, UK, it was established in 2012 as a subsidiary of the Wellcome Trust, an independent global charitable foundation. Syncona's mission is to unlock the potential of revolutionary science to transform the lives of patients with serious medical needs. It does this by partnering with leading scientists, entrepreneurs, and management teams, and providing long-term capital, strategic insight, and operational support. The company invests in and builds companies that explore cutting-edge technologies, such as gene therapy, cell therapy, and precision medicine. Its portfolio includes several successful businesses, such as Nightstar Therapeutics, Gyroscope Therapeutics, and Freeline Therapeutics, that are developing groundbreaking treatments for diseases such as blindness, hemophilia, and Parkinson's.